September 30, 2019 Dataset Open Access

Harding, Rachel; Hutchinson, Ashley; Seitova, Alma; Arrowsmith, Cheryl; Edwards, Aled

Citation Style Language JSON Export

{
  "publisher": "Zenodo", 
  "DOI": "10.5281/zenodo.3555358", 
  "title": "Large-scale purification of Q23 HTT from Sf9 2019/09/30", 
  "issued": {
    "date-parts": [
      [
        2019, 
        9, 
        30
      ]
    ]
  }, 
  "abstract": "<p><strong>Project:&nbsp;</strong>Biophysical investigation of purified HTT protein samples</p>\n\n<p><strong>Experiment:&nbsp;</strong>Large-scale purification of Q23 HTT from Sf9&nbsp;</p>\n\n<p><strong>Date completed:&shy;&nbsp;</strong>2019/09/30</p>\n\n<p><strong>Rationale:&nbsp;</strong>HTT samples are to be purified from different systems for subsequent biophysical and structural studies.&nbsp;</p>", 
  "author": [
    {
      "family": "Harding, Rachel"
    }, 
    {
      "family": "Hutchinson, Ashley"
    }, 
    {
      "family": "Seitova, Alma"
    }, 
    {
      "family": "Arrowsmith, Cheryl"
    }, 
    {
      "family": "Edwards, Aled"
    }
  ], 
  "note": "Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, S\u00e3o Paulo Research Foundation-FAPESP, Takeda, and Wellcome.", 
  "type": "dataset", 
  "id": "3555358"
}